BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 991 filers reported holding BAXTER INTL INC in Q3 2022. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $853,981 | -58.0% | 22,628 | -49.4% | 0.08% | -57.9% |
| Q2 2023 | $2,035,484 | +385.6% | 44,677 | +332.3% | 0.19% | +287.8% |
| Q1 2023 | $419,147 | +73.9% | 10,334 | +131.0% | 0.05% | -2.0% |
| Q3 2022 | $241,000 | -36.2% | 4,473 | -23.9% | 0.05% | -65.5% |
| Q2 2022 | $378,000 | -83.8% | 5,881 | -80.5% | 0.14% | -83.5% |
| Q1 2022 | $2,339,000 | +269.5% | 30,166 | +309.3% | 0.88% | +418.9% |
| Q4 2021 | $633,000 | +21.5% | 7,370 | +13.8% | 0.17% | +101.2% |
| Q2 2021 | $521,000 | +54.6% | 6,476 | +54.4% | 0.08% | -56.0% |
| Q4 2020 | $337,000 | -87.1% | 4,194 | -87.1% | 0.19% | -87.5% |
| Q3 2020 | $2,611,000 | +223.9% | 32,471 | +230.1% | 1.53% | +223.3% |
| Q2 2019 | $806,000 | -20.4% | 9,836 | -36.8% | 0.47% | +94.7% |
| Q1 2018 | $1,012,000 | +138.1% | 15,564 | +136.7% | 0.24% | -5.1% |
| Q4 2017 | $425,000 | -85.8% | 6,576 | -88.6% | 0.26% | -70.8% |
| Q1 2017 | $3,003,000 | +765.4% | 57,909 | +639.4% | 0.88% | +81.0% |
| Q4 2016 | $347,000 | – | 7,832 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |